Back to Search
Start Over
Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy.
- Source :
- Journal of Clinical Oncology; 2/20/2012, Vol. 30 Issue 6, p631-636, 6p
- Publication Year :
- 2012
Details
- Language :
- English
- ISSN :
- 0732183X
- Volume :
- 30
- Issue :
- 6
- Database :
- Supplemental Index
- Journal :
- Journal of Clinical Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 104519895